Jingliang Wu

Weifang University of Science and Technology

H指数:18

被引数:903

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Biomimetic liposomes co-loaded with ginsenoside Rg1 & curcumin inhibit the development of oral squamous cell carcinoma

仿生脂质体共载人参皂苷Rg1和姜黄素抑制口腔鳞状细胞癌的发展

Journal of Drug Delivery Science and Technology

IF4.9

2026-07-280

PRE

Combination Therapeutic Effect of Asiatic Acid & Curcumin-Loaded Liposomes Modified by Neutrophil Extracellular Traps for the Treatment of Oral Squamous Cell Carcinoma

International Journal of Nanomedicine

IF6.5

2026-07-140

Co-loaded aspirin and doxorubicin by chondroitin sulphate nanoparticles inhibited metastasis of breast cancer by squelching circulating tumor microemboli

硫酸软骨素纳米颗粒共载阿司匹林和道诺霉素通过消除循环肿瘤微栓子抑制了乳腺癌的转移。

colloids and surfaces b biointerfaces

IF0

2025-07-090

PRE

pH-sensitive hyaluronic acid nanomicelles for co-delivery of capsaicin and doxorubicin enhance the treatment of anaplastic thyroid carcinoma

pH敏感的透明质酸纳米胶束用于共递送辣椒素和柔红霉素，可增强未分化甲状腺癌的治疗效果。

colloids and surfaces b biointerfaces

IF0

2025-05-290

PRE

Reprogramming Retinal Microglia Polarization by Efferocytosis-Mimicking Nanoparticles for Ameliorating Diabetic Retinopathy

通过吞噬凋亡细胞样纳米颗粒重编程视网膜小胶质细胞极化以改善糖尿病视网膜病变

ACS APPLIED MATERIALS & INTERFACES

IF8.2

2025-05-070

PRE

Study on the Construction and Anti-Tumor Effect of aPDL1/aMUC1 Double Antibody Modification of Doxorubicin Liposome

ACS OMEGA

IF4.3

2025-03-010

OAAI

Mediating effects of social detachment in young and middle-aged stroke patients between stigma and ability to return to work

FRONTIERS IN PUBLIC HEALTH

IF3.4

2025-01-170

OAAI

The role of sodium butyrate in modulating growth, intestinal health, and antimicrobial efficacy in turbot (Scophthalmus maximus L.) fed high soy diets

SCIENTIFIC REPORTS

IF3.9

2024-12-300

OAAI

The pH-sensitive chondroitin sulphate-based nanoparticles for co-delivery of doxorubicin and berberine enhance the treatment of breast cancer

INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES

IF8.5

2024-11-010

PRE

Renshen Yangrong decoction for secondary malaise and fatigue: network pharmacology and Mendelian randomization study

FRONTIERS IN NUTRITION

IF5.1

2024-06-201

OAAI

Enhancing the Inhibition of Breast Cancer Growth Through Synergistic Modulation of the Tumor Microenvironment Using Combined Nano-Delivery Systems

INTERNATIONAL JOURNAL OF NANOMEDICINE

IF6.5

2024-06-010

OAAI

Anti-tumor therapy of glycyrrhetinic acid targeted liposome co-delivery of doxorubicin and berberine for hepatocellular carcinoma

DRUG DELIVERY AND TRANSLATIONAL RESEARCH

IF5.5

2024-01-184

PRE

A pH-responsive hyaluronic acid nano-vehicle co-encapsulating doxorubicin and all-trans retinoic acid for the inhibition of hepatic stellate cell-induced tumor growth and metastasis

MOLECULAR MEDICINE REPORTS

IF3.5

2023-06-093

OAAI

Bortezomib-loaded mixed micelles realize a three-in-one effect for enhanced breast cancer treatment

BIOMATERIALS SCIENCE

IF5.7

2023-01-014

PRE

Substance P&dimethyloxallyl glycine-loaded carboxymethyl chitosan/gelatin hydrogel for wound healing

JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A

IF3.9

2022-12-079

PRE

Therapeutic Response of Multifunctional Lipid and Micelle Formulation in Hepatocellular Carcinoma

多功能脂质和胶束制剂在肝细胞癌中的治疗反应

ACS APPLIED MATERIALS & INTERFACES

IF8.2

2022-09-278

PRE

GA&HA-Modified Liposomes for Co-Delivery of Aprepitant and Curcumin to Inhibit Drug-Resistance and Metastasis of Hepatocellular Carcinoma (vol 17, pg 2559, 2022)

INTERNATIONAL JOURNAL OF NANOMEDICINE

IF6.5

2022-07-010

OAAI

GA&HA-Modified Liposomes for Co-Delivery of Aprepitant and Curcumin to Inhibit Drug-Resistance and Metastasis of Hepatocellular Carcinoma

INTERNATIONAL JOURNAL OF NANOMEDICINE

IF6.5

2022-06-0131

OAAI

Combined anti-hepatocellular carcinoma therapy inhibit drug-resistance and metastasis via targeting substance P-hepatic stellate cells-hepatocellular carcinoma axis

BIOMATERIALS

IF12.9

2021-09-0136

PREAI

Dual-Ligand-Modified Liposomes Co-Loaded with Anti-Angiogenic and Chemotherapeutic Drugs for Inhibiting Tumor Angiogenesis and Metastasis

INTERNATIONAL JOURNAL OF NANOMEDICINE

IF6.5

2021-06-0112

OAAI

Jingliang Wu

个人简介

教育背景

工作经历

荣誉奖项

研究方向